Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MAGiC - Congenital Heart DIsease

NCT: NCT07812818 · NOT_YET_RECRUITING

NCT IDNCT07812818
StatusNOT_YET_RECRUITING
Start Date2026-10-31
Completion2029-12-31
SponsorStereotaxis (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this observational study is to collect real world performance and to confirm the effectiveness and safety of the MAGiC Ablation Catheter for the treatment of supraventricular tachycardia in adult patients with congenital heart disease: To estimate the rate of acute procedural success and to estimate the rate of chronic success through 6 months post procrdure. Participants will be asked to have a cardiac ablation procedure and visit their doctor at 1 week, 1 month and 6 monhs post procedure.

Frequently Asked Questions

What is MAGiC - Congenital Heart DIsease?

MAGiC - Congenital Heart DIsease is a clinical trial registered under NCT07812818. Current status: NOT_YET_RECRUITING.

What is the status of NCT07812818?

The current status of NCT07812818 (MAGiC - Congenital Heart DIsease) is: NOT_YET_RECRUITING.

When did MAGiC - Congenital Heart DIsease start?

MAGiC - Congenital Heart DIsease started on 2026-10-31.

Related Devices

PMA P240014Cardiac ablation percutaneous catheterStereotaxis, Inc. K250590MAGiC Sweep™ EP Mapping CatheterStereotaxis, Inc. K183027Steerable catheter control systemStereotaxis, Inc. K192775Niobe® Magnetic Navigation System (MNS) with Navigant Workstation (NWS) and CardiodriStereotaxis, Inc. K193147Stereotaxis Genesis RMN with Navigant Workstation (NWS) and Cardiodrive SystemStereotaxis, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑